HAEMONETICS CORP/MASS (HAE)
US4050241003 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to HAE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 112. This target is 31.1% above the current price.
HAE was analyzed by 14 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about HAE.
In the previous month the buy percentage consensus was at a similar level.
HAE was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-15 | Needham | Reiterate | Buy -> Buy |
| 2024-11-08 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-11-08 | Raymond James | Upgrade | Outperform -> Strong Buy |
| 2024-09-23 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-09-13 | CL King | Initiate | Buy |
| 2024-09-11 | B of A Securities | Initiate | Neutral |
| 2024-09-10 | BTIG | Initiate | Buy |
| 2024-08-22 | Citigroup | Maintains | Neutral -> Neutral |
| 2024-08-13 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-08-09 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-06-12 | Needham | Upgrade | Hold -> Buy |
| 2024-05-10 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-05-10 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-05-10 | Needham | Reiterate | Hold |
| 2024-04-12 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-02-13 | Barrington Research | Reiterate | Outperform -> Outperform |
| 2023-11-03 | Barrington Research | Maintains | Outperform -> Outperform |
| 2023-10-02 | Citigroup | Maintains | Neutral -> Neutral |
| 2023-08-09 | Barrington Research | Maintains | Outperform -> Outperform |
| 2023-05-12 | Barrington Research | Maintains | Outperform -> Outperform |
| 2023-05-12 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2023-05-12 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-02-08 | Barrington Research | Maintains | Outperform |
| 2023-02-08 | Mizuho | Maintains | Buy |
| 2023-02-08 | Morgan Stanley | Maintains | Equal-Weight |
| 2023-02-08 | Citigroup | Maintains | Neutral |
| 2023-01-24 | Mizuho | Maintains | Buy |
| 2023-01-06 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-12-12 | Citigroup | Maintains | Neutral |
| 2022-11-08 | Barrington Research | Maintains | Outperform |